title: Management of atrial fibrillation in patients with congestive heart failure.
abstract: An increase in the prevalence of both atrial fibrillation and congestive heart failure is occurring in part because of the demographic shift toward an aging population. These two clinical entities often coexist in the same patient, resulting in the worsening of symptoms and prognosis, rendering their management even more challenging. A large clinical trial is currently examining whether a rhythm-control strategy is superior to a rate-control strategy in patients with congestive heart failure. New nonpharmacologic therapies such as pulmonary vein isolation are undergoing clinical investigation and may also alter the management of these patients. At present, therapy for atrial fibrillation in patients with congestive heart failure should aim first at controlling heart rate to provide symptomatic relief; then sinus rhythm should be restored if symptoms persist or if congestive heart failure worsens. For a more definitive approach in managing these patients, the authors await further clinical trial data.
authors.affiliation: Department of Medicine, Montreal Heart Institute, University of Montreal, Quebec, Canada.
authors.forename: Marcio Lerch
authors.initials: ML
authors.lastname: Stürmer
authors.forename: Mario
authors.initials: M
authors.lastname: Talajic
authors.forename: Bernard
authors.initials: B
authors.lastname: Thibault
authors.forename: Peter G
authors.initials: PG
authors.lastname: Guerra
authors.forename: Marc
authors.initials: M
authors.lastname: Dubuc
authors.forename: Paul
authors.initials: P
authors.lastname: Novak
authors.forename: Denis
authors.initials: D
authors.lastname: Roy
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy*; D002304:Cardiac Pacing, Artificial / Q000379:methods; D017115:Catheter Ablation / Q000379:methods; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000150:complications*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D011379:Prognosis
chemical_list: D000889:Anti-Arrhythmia Agents